Remy Lazarovici
Chief Commercial Officer @ Avelios Medical
Munich, Germany
Remy Lazarovici is a seed investor at Avelios Medical in Munich focused on Software and Artificial Intelligence. Remy A. Lazarovici is based out of Munich, Bayern and is the Chief Commercial Officer of Avelios Medical. Remy previously worked at Celonis as a Managing Director for Germany, Austria, and Switzerland(DACH). Remy A. Lazarovici attended the Tel Aviv University.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Remy Lazarovici invests in
Stages Remy Lazarovici invests in
Countries Remy Lazarovici invests in
Round sizes
Round size
- Pre-Seed
- $1.7M–$5.1M
Investment Focus
Industry
- Software 3 (75%)
- Artificial Intelligence 3 (75%)
- PaaS 2 (50%)
- SaaS 2 (50%)
- Marketing 2 (50%)
Stage
- Seed 2 (50%)
- Pre-Seed 2 (50%)
Country
- Switzerland 2 (50%)
- Poland 1 (25%)
- United Kingdom 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Userled
|
Userled is a no-code interface and AI-powered platform that automates the distribution of personalizing marketing experiences across all ad and email platforms, empowering revenue teams with person-level engagement insights without cookies. Customers can deploy multiple personalized campaigns across all their target platforms from email, Linkedin,Meta, and more. | $5.1M / Pre-Seed / Aug 09, 2024 | |
viso.ai
|
The Viso Suite provides the world's first end-to-end computer vision application platform for businesses to build and scale computer vision applications dramatically faster and easier. The model-driven infrastructure is used by some of the world's leading organizations across industries.The end-to-end platform provides a no-codeinterface to increase productivity, maximize system compatibility, and establish standardization across a portfolio of different computer vision applications. Applications built with the Viso Suite are flexible, easily upgraded, and can be ported across different hardware platforms (cameras, computing) with little or no modification, providing a solution that future-proofs customers' investment in computer vision application development. | Seed / Oct 25, 2023 | |
viso.ai
|
The Viso Suite provides the world's first end-to-end computer vision application platform for businesses to build and scale computer vision applications dramatically faster and easier. The model-driven infrastructure is used by some of the world's leading organizations across industries.The end-to-end platform provides a no-codeinterface to increase productivity, maximize system compatibility, and establish standardization across a portfolio of different computer vision applications. Applications built with the Viso Suite are flexible, easily upgraded, and can be ported across different hardware platforms (cameras, computing) with little or no modification, providing a solution that future-proofs customers' investment in computer vision application development. | $9.7M / Seed / Oct 25, 2023 | |
Demoboost
|
Demoboost helps software companies deliver demo experience that sells.Presales, sales, marketing and customer success teams use Demoboost to easily and quickly prepare, share and track product demos with their customers.They avoid spending a lot of time preparing demos or relying on generic ones, frustrating customers with long wait times andstressing about unstable infrastructure.Instead, they use Demoboost and enjoy more effective teams, happier customers and better bottom line.Come and join the demo experience revolution. | $1.7M / Pre-Seed / Oct 06, 2022 |
Co-Investors
About Avelios Medical
Avelios is a modular clinic platform that digitizes and optimizes all clinic processes in a user-friendly way. The state-of-the-art software supports all staff in their daily work and additionally enables the development and use of innovations such as artificial intelligence, Big Data, telemedicine, patient applications and wearables tofundamentally improve patient care and research.
Avelios Medical Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Christian Albrecht
Co-Founder & Managing Director
|
|||
|
Nicolas Jakob
Co-Founder & Managing Director
|
|||
|
Remy Lazarovici
Chief Commercial Officer
|
|||
Sebastian Krammer
Co-Founder
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Remy Lazarovici invest in?
Remy Lazarovici invests primarily in Software, Artificial Intelligence and PaaS startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Remy Lazarovici's check size?
Remy Lazarovici typically joins rounds of $1.7M–$5.1M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Remy Lazarovici participates in.
When did Remy Lazarovici last invest?
The most recent investment recorded for Remy Lazarovici closed in Aug 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
